AI-generated draft from CMS source. Review and verify clinical accuracy before use.
CLINICAL STAGE / CARE PATHWAY
Patient is currently in the therapeutic intervention stage for chronic pain management after a comprehensive evaluation confirmed the pain source and prior conservative treatments were insufficient. The clinical presentation supports progression to a nerve block procedure targeting the stellate ganglion for sympathetic nerve-mediated pain syndromes.
– Sequencing logic: Nerve blocks are typically performed after failure of conservative therapies and confirmatory diagnostic evaluation. Imaging guidance may be used to enhance accuracy when indicated.
ICD-10 / DIAGNOSIS SUPPORT
Diagnosis support includes chronic pain syndromes consistent with sympathetic nervous system overactivity or neuropathic pain with documentation supporting the clinical rationale for stellate ganglion blockade.
– Example ICD-10 options:
G89.28 – Other chronic postprocedural pain
G90.50 – Complex regional pain syndrome I, unspecified
I73.01 – Raynaud's syndrome with gangrene
B02.22 – Postherpetic trigeminal neuralgia
SUBJECTIVE / HPI SUPPORT
Patient reports persistent pain characterized as burning, stabbing, or aching localized to the head, neck, or upper extremities, with associated symptoms suggestive of autonomic dysfunction such as temperature changes or swelling. Pain has been present for greater than three months despite analgesic medication trials, physical therapy, and activity modification.
– Edit if needed:
right-sided pain
left-sided pain
bilateral distribution
associated paresthesia
pain worse with cold exposure
CONSERVATIVE CARE / PRIOR TREATMENT
Patient has undergone a trial of conservative therapies including pharmacologic management with NSAIDs, neuropathic pain medications, physical therapy, and activity modification without sufficient pain relief or functional improvement. Prior diagnostic nerve blocks or imaging studies have been performed to localize the pain generator.
– Common conservative treatments:
Medication trials with gabapentin or pregabalin
Physical therapy directed at symptom management
Activity and ergonomic modification
Prior local anesthetic nerve block as diagnostic trial
OBJECTIVE / DIAGNOSTIC SUPPORT
Physical examination findings and diagnostic imaging are clinically consistent with sympathetic nerve-mediated pain. No contraindications to the procedure identified. Prior diagnostic nerve block yielded temporary pain relief supporting the target of the stellate ganglion for therapeutic intervention.
ASSESSMENT
Assessment: Chronic sympathetically maintained pain with autonomic features, refractory to conservative management and supported by diagnostic nerve block response. Medical necessity is supported for stellate ganglion nerve block as a therapeutic intervention to reduce pain and improve function.
PLAN / NEXT STEP
Plan: Proceed with stellate ganglion nerve block using appropriate anesthetic agent under imaging guidance to maximize safety and accuracy. The procedure will target the clinically indicated cervical sympathetic chain level based on symptom distribution and prior diagnostic findings. Risks, benefits, and alternatives have been reviewed with the patient.
– Edit if needed:
right-sided
left-sided
cervical level C6
imaging guidance with fluoroscopy or ultrasound
PROCEDURE-SPECIFIC CLINICAL REQUIREMENTS
Prior diagnostic nerve block demonstrated at least temporary improvement in pain and function, supporting progression to therapeutic nerve blockade. Imaging guidance is utilized per provider expertise and patient anatomy to ensure accurate delivery. Duration of symptoms exceeds three months despite conservative treatment.
FOLLOW-UP / RESPONSE DOCUMENTATION
Patient will be monitored post-procedure for pain relief, functional improvement, and any adverse effects. Follow-up assessments will document percentage of pain reduction, duration of relief, and impact on activities of daily living. Subsequent treatment planning will be based on therapeutic response.
– Edit if needed:
greater than 50% pain reduction
relief lasting several weeks to months
MISSING DOCUMENTATION CHECK
– Documentation items to confirm:
Symptom duration
Functional limitation
Prior conservative care documentation
Prior medication trials
Imaging correlation
Diagnostic nerve block response
Pain scores before and after diagnostic blocks
Laterality and cervical level targeted
Diagnosis and ICD-10 support
APPEAL / PEER-TO-PEER CLINICAL SUPPORT
The requested stellate ganglion nerve block is clinically supported by the patient’s chronic pain diagnosis, documented failure of conservative therapies, positive diagnostic nerve block response, and clinical correlation guiding therapeutic intervention. Medical necessity is demonstrated for targeted treatment to reduce pain and improve function.
COVERED SERVICES AND CODES
– Nerve blockade procedures for diagnosis and treatment of chronic pain and neuropathy as defined in LCD L35456 (version 66).
– Covered CPT/HCPCS codes include 64510 (stellate ganglion block) and other peripheral nerve blocks but exclude epidural blocks covered separately under Noridian LCD L39240/A58993.
– Use of imaging guidance (fluoroscopy, CT, or ultrasound) required for certain somatic nerve blocks; fluoroscopy or CT only for epidural injections per separate coverage.
MEDICAL NECESSITY AND DIAGNOSTIC CRITERIA
– Pain must be chronic (≥3 months) and documented as causing patient distress with insufficient response to conservative therapy.
– Diagnostic nerve blocks may be performed to identify pain source and guide further treatment.
– Therapeutic blocks indicated for conditions responsive to nerve blockade (e.g., cancer pain with sympathetic overactivity).
– Prior clinical evaluation required with documentation of pain source and treatment of any underlying pathology.
– Multi-disciplinary evaluation recommended for persistent or refractory pain.
NONCOVERED SERVICES AND DENIAL RISKS
– Nerve blockade and electrical stimulation for metabolic peripheral neuropathy are non-covered as per LCD L35456 due to lack of evidence for efficacy.
– Imaging guidance for these non-covered injections is also non-covered.
– Use of peripheral nerve blocks for systemic neuropathies or multiple neuropathies caused by systemic diseases considered investigational.
– Claims subject to review and recoupment if submitted for non-covered indications.
DOCUMENTATION EXPECTATIONS
– Complete and legible medical record documentation required with patient identifiers, dates of service, and provider identity on every page.
– Documentation must clearly support the specific diagnosis codes submitted and services performed.
– Records must be readily available for contractor review upon request.
BILLING AND CODING GUIDANCE
– Do not separately bill fluoroscopy codes (77002, 77003) with modifier 59 when imaging guidance is included in the descriptor of the nerve block CPT code.
– Follow use of appropriate CPT/HCPCS codes consistent with procedure performed and anatomical site.
– Adhere to frequency and utilization guidelines discouraging multiple injections per day on multiple days per week for systemic neuropathies.
PROVIDER QUALIFICATIONS
– Providers performing nerve blocks must be appropriately trained or credentialed through recognized residency/fellowship programs or accredited certification.
– Hospital credentialing for procedure in inpatient setting must be mirrored for outpatient setting if applicable.
– Adequate training in anatomy, pharmacodynamics, procedural technique, and imaging modalities essential for coverage determination.
IMAGING GUIDANCE
– Required for somatic nerve blocks using fluoroscopy, CT, or ultrasound as indicated.
– Only fluoroscopy or CT guidance is covered for epidural injections per separate LCD.
– Use of ultrasound guidance for peripheral nerve blocks aligned with current coverage requirements.
FREQUENCY AND UTILIZATION LIMITS
– Multiple injections per day on multiple days per week for systemic or metabolic neuropathies not medically necessary.
– Repeat procedures require supporting documentation demonstrating continued medical necessity.
NOT CLEARLY STATED IN SOURCE
– Specific frequency limits or intervals for individual nerve block procedures beyond general utilization guidelines.
– Detailed anesthesia or sedation requirements or limitations beyond provider training.
– Modifier usage beyond prohibition of 59 modifier with included imaging codes.
RELATED POLICIES
– Refer to LCD L35456 for comprehensive nerve blockade coverage criteria.
– Epidural blocks covered under Noridian LCD L39240/A58993.
– Injections for tendon, ligament, ganglion cyst, tunnel syndromes under LCD 34218.
SUMMARY ON DENIAL TRIGGERS
– Nerve blocks for metabolic peripheral neuropathy or non-covered neuropathic conditions.
– Missing or inadequate documentation supporting diagnosis and medical necessity.
– Improper use of imaging codes or unsupported billing of imaging separately.
– Procedures performed by unqualified providers not meeting credentialing requirements.